Axon Enterprise, Inc. (NASDAQ:AXON) Receives Consensus Recommendation of “Buy” from Brokerages

Axon Enterprise, Inc. (NASDAQ:AXON) has been assigned a consensus rating of “Buy” from the thirteen brokerages that are currently covering the stock, Marketbeat.com reports. Thirteen analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have covered the stock in the last year is $460.33.

Several equities research analysts recently weighed in on AXON shares. Robert W. Baird upped their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. JMP Securities upped their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $500.00 to $700.00 in a report on Tuesday. Finally, Northland Securities upped their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 47,314 shares of the company’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $400.07, for a total value of $18,928,911.98. Following the transaction, the chief executive officer now owns 2,983,802 shares in the company, valued at $1,193,729,666.14. This represents a 1.56 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now owns 2,392 shares in the company, valued at $1,631,487.52. This represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 137,921 shares of company stock valued at $63,093,907. 6.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Axon Enterprise

A number of hedge funds have recently added to or reduced their stakes in the company. Oddo BHF Asset Management Sas acquired a new position in Axon Enterprise in the third quarter worth approximately $1,522,000. Denver PWM LLC increased its holdings in Axon Enterprise by 69.7% in the third quarter. Denver PWM LLC now owns 414 shares of the biotechnology company’s stock worth $165,000 after buying an additional 170 shares during the last quarter. Tidal Investments LLC increased its holdings in Axon Enterprise by 13.8% in the third quarter. Tidal Investments LLC now owns 3,250 shares of the biotechnology company’s stock worth $1,299,000 after buying an additional 394 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Axon Enterprise in the third quarter worth approximately $759,000. Finally, Sanctuary Advisors LLC increased its holdings in Axon Enterprise by 1,164.3% in the third quarter. Sanctuary Advisors LLC now owns 34,301 shares of the biotechnology company’s stock worth $13,707,000 after buying an additional 31,588 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

AXON stock opened at $689.78 on Friday. The company has a market capitalization of $52.60 billion, a P/E ratio of 178.24, a PEG ratio of 14.74 and a beta of 1.01. The company has a 50-day simple moving average of $504.47 and a 200 day simple moving average of $387.43. Axon Enterprise has a fifty-two week low of $231.83 and a fifty-two week high of $695.94. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.